Critical review of laboratory investigations in clinical practice guidelines: Proposals for the description of investigation

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 6, 2013, Pages 1217-1226

  Aakre, Kristin M ^a   Langlois, Michel R ^b   Watine, Joseph ^c   Barth, Julian H ^d   Baum, Hannsjörg ^e   Collinson, Paul ^d   Laitinen, Païvi ^f   Oosterhuis, Wytze P ^g  

^a UNIVERSITY OF BERGEN   (Norway)

^b General Hospital St Jan   (Belgium)

^c Hôpital de la Chartreuse   (France)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e Regionale Kliniken Holding RKH GmbH   (Germany)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g Sittard Geleen Heerlen   (Netherlands)

Author keywords

Clinical chemistry tests; Guideline; Laboratory personnel; Quality improvement

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CREATINE KINASE MB; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TROPONIN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHECKLIST; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; DYSLIPIDEMIA; FOLLOW UP; FOOD INTAKE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY; LABORATORY TEST; MEDICAL SPECIALIST; PATIENT INFORMATION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; TRIACYLGLYCEROL BLOOD LEVEL;

HUMANS; LABORATORIES; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT;

EID: 84882248074     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0574     Document Type: Article

References (28)

1. Department of Health Pathology Modernization Team. Modernising Pathology Services (http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/@dh/@en/ documents/digitalasset/dh-4073112.pdf). Accessed 27 August, 2012.
2. Hallworth MJ. The '70% claim':what is the evidence base? Ann Clin Biochem 2011;48:487-8.
3. Plebani M. Exploring the iceberg of errors in laboratory medicine. Clin Chim Acta 2009;404:16-23.
4. Lapworth R, Tarn AC. Commentary on the British Thoracic Society guidelines for the investigation of unilateral pleural effusion in adults. Ann Clin Biochem 2006;43:17-22.
5. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
6. National Collaborating Centre for Chronic Conditions. Chronic kidney disease: national guideline for early identification and management in adults in primary and secondary care. London: Royal College of Physicians, 2008.
7. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011;34:S11-61.
8. Scottish Intercollegiate Guideline Network.122. Prevention and management of venous tromboembolism (http://wwwsignacuk/guidelines/fulltext/122/indexhtml) . Accessed 27 August, 2012.
9. Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC/EAS guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011;217:3-46.
10. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
11. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000;160:1573-5.
12. National Collaborating Centre for Chronic Conditions. Prostate cancer. Diagnosis and treatment. London: Royal College of Physicians, 2008.
13. Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, et al. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 2009;147:22-42.
14. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
15. Shipitsyna E, Savicheva A, Solokovskiy E, Ballard RC, Domeika M, Unemo M, et al. Guidelines for the laboratory diagnosis of mycoplasma genitalium infections in East European countries. Acta Derm Venereol 2010;90:461-7.
16. Zini G, D'Onofrio G, Briggs C, Erber W, Jou JM, Lee SH, et al. ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol 2011;34:107-16.
17. Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. J Am Med Assoc 2010;303:1151-8.
18. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-9.
19. Clinical and Laboratory Standards Institute. Collection, transport and processing of blood specimens for testing plasma based coagulation assays and molecular hemostasis assays; approved guideline-5th ed. H21-A5 2008;28:No. 5.
20. Brien WF, Schaus MR, Cooper KE, O'Keefe BT, Inwood M. Lupus anticoagulant testing: effect of the platelet count on the activated partial thromboplastin time. Br J Biomed Sci 1993;50:114-6.
21. Laposata ME, Laposata M, Van Cott EM, Buchner DS, Kashalo MS, Dighe AS. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med 2004;128:1424-7.
22. Aakre KM, Oosterhuis WP, Sandberg S. How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests ? Scand J Clin Lab Invest 2012;72:143-51.
23. Vasikaran SD, Lai LC, Sethi S, Lopez JB, Sikaris KA. Quality of interpretative commenting on common clinical chemistry results in the Asia-Pacific region and Africa. Clin Chem Lab Med 2009;47:963-70.
24. Lim EM, Sikaris KA, Gill J, Calleja J, Hickman PE, Beilby J, et al. Quality assessment of interpretative commenting in clinical chemistry. Clin Chem 2004;50:632-7.
25. Collinson PO, Van Dieijen-Visser MP, Pulkki K, Hammerer-Lercher A, Suvisaari J, Ravkilde J, et al. Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines ? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem 2011;58:305-6.
26. Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, et al. An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem Lab Med 2012;50:411-3.
27. Aakre KM, Thue G, Subramaniam-Haavik S, Bukve T, Morris H, Muller M, et al. Postanalytical external quality assessment of urine albumin in primary health care: an international survey. Clin Chem 2008;54:1630-6.
28. Aakre KM, Thue G, Svarstad E, Skadberg O, Sandberg S. Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care. Clin Chim Acta 2011;412:1138-42.